Symbols / GRAL Stock $54.42 +7.44% GRAIL, Inc.

Healthcare • Diagnostics & Research • United States • NMS
GRAL (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Diagnostics & Research
CEO Mr. Robert P. Ragusa
Exch · Country NMS · United States
Market Cap 2.23B
Enterprise Value 1.38B
Income -408.35M
Sales 147.17M
FCF (ttm) -108.89M
Book/sh 63.92
Cash/sh 22.05
Employees 910
Insider 10d —
IPO Jun 12, 2024
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E —
Forward P/E -6.46
PEG —
P/S 15.17
P/B 0.85
P/C —
EV/EBITDA -3.66
EV/Sales 9.40
Quick Ratio 11.58
Current Ratio 11.97
Debt/Eq 2.13
LT Debt/Eq —
EPS (ttm) -11.11
EPS next Y -8.42
EPS Growth —
Revenue Growth 14.00%
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) 2026-05-05
Earnings (prior) 2026-02-19
ROA -11.31%
ROE -16.07%
ROIC —
Gross Margin 48.46%
Oper. Margin -285.37%
Profit Margin -277.46%
Shs Outstand 41.02M
Shs Float 34.63M
Insider Own 4.69%
Instit Own 74.73%
Short Float 19.27%
Short Ratio 7.93
Short Interest 6.99M
52W High 118.84
vs 52W High -54.21%
52W Low 29.95
vs 52W Low 81.70%
Beta —
Impl. Vol. 91.09%
Rel Volume 0.47
Avg Volume 1.27M
Volume 590.72K
Target (mean) $67.71
Tgt Median $65.00
Tgt Low $54.00
Tgt High $82.00
# Analysts 7
Recom Buy
Prev Close $50.65
Price $54.42
Change 7.44%
About

GRAIL, Inc., a commercial-stage healthcare company, provides multi-cancer early detection testing and services in the United States and internationally. It offers Galleri, a cancer screening test for asymptomatic individuals over 50 years of age; and a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients with clinical suspicion of cancer. The company also provides development services, including support for ongoing clinical studies, pilot testing, research, and therapy development. In addition, its precision oncology portfolio consists of n RUO-targeted methylation-based platform that enables applications for disease prognostication, risk stratification, minimal residual disease detection, and recurrence and relapse monitoring. The company was incorporated in 2015 and is headquartered in Menlo Park, California.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$67.71
Mean price target
2. Current target
$54.42
Latest analyst target
3. DCF / Fair value
$-47.78
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$54.42
Low
$54.00
High
$82.00
Mean
$67.71

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-04-10 init Mizuho — → Neutral $58
2026-04-10 init Piper Sandler — → Neutral $54
2026-03-30 main Guggenheim Buy → Buy $75
2026-02-24 main Morgan Stanley Equal-Weight → Equal-Weight $60
2026-02-20 main Canaccord Genuity Buy → Buy $80
2026-02-20 main Baird Outperform → Outperform $82
2026-02-17 init Baird — → Outperform $113
2026-01-26 main Guggenheim Buy → Buy $130
2025-12-02 main Morgan Stanley Equal-Weight → Equal-Weight $110
2025-11-17 main Canaccord Genuity Buy → Buy $105
2025-11-12 up Guggenheim Neutral → Buy $100
2025-10-22 main Canaccord Genuity Buy → Buy $85
2025-10-03 main Canaccord Genuity Buy → Buy $75
2025-05-14 main Canaccord Genuity Buy → Buy $43
2025-04-21 init Canaccord Genuity — → Buy $32
2025-03-18 main Morgan Stanley Equal-Weight → Equal-Weight $20
2024-11-27 init Morgan Stanley — → Equal-Weight $16
2024-10-17 init Guggenheim — → Neutral —
News
RSS: Latest GRAL news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-04-15 SUMME GREGORY L Director — 631 $49.79 $31,417
2026-04-15 MIZELL STEVEN CRAIG Director — 396 $49.79 $19,717
2026-04-15 CHASE WILLIAM J Director — 408 $49.79 $20,314
2026-04-08 RAGUSA ROBERT P. Chief Executive Officer — 123,502 $49.92 $6,164,923
2026-04-08 FREIDIN AARON Chief Financial Officer — 45,806 $49.92 $2,286,526
2026-03-09 RAGUSA ROBERT P. Chief Executive Officer — 8,441 $46.73 $409,246
2026-03-09 FREIDIN AARON Chief Financial Officer — 3,147 $46.74 $154,062
2026-03-09 OFMAN JOSHUA J. President — 3,627 $46.74 $177,227
2026-03-02 RAGUSA ROBERT P. Chief Executive Officer — 37,504 $50.09 $1,881,417
2026-03-02 FREIDIN AARON Chief Financial Officer — 9,573 $50.09 $480,244
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
147.17
+17.18%
125.59
+34.90%
93.11
+67.61%
55.55
Operating Revenue
147.17
+17.18%
125.59
+34.90%
93.11
+67.61%
55.55
Cost Of Revenue
209.75
+3.01%
203.62
+7.90%
188.72
+9.72%
172.00
Reconciled Cost Of Revenue
209.75
+3.01%
203.62
+7.90%
188.72
+9.72%
172.00
Gross Profit
-62.57
+19.80%
-78.02
+18.40%
-95.61
+17.89%
-116.45
Operating Expense
471.59
-31.67%
690.20
-1.58%
701.30
+12.03%
626.01
Research And Development
195.79
-39.27%
322.38
-4.83%
338.75
+2.78%
329.58
Selling General And Administration
275.80
-25.02%
367.82
+1.45%
362.56
+22.31%
296.44
Selling And Marketing Expense
116.69
-24.20%
153.96
-5.14%
162.29
+32.67%
122.33
General And Administrative Expense
159.10
-25.60%
213.86
+6.79%
200.27
+15.03%
174.11
Other Gand A
159.10
-25.60%
213.86
+6.79%
200.27
+15.03%
174.11
Total Expenses
681.34
-23.77%
893.82
+0.43%
890.02
+11.53%
798.01
Operating Income
-534.16
+30.47%
-768.22
+3.60%
-796.92
-7.33%
-742.46
Total Operating Income As Reported
-562.16
+74.32%
-2,189.16
-44.46%
-1,515.38
+72.16%
-5,442.89
EBITDA
-377.82
+38.08%
-610.17
+4.40%
-638.22
-8.60%
-587.70
Normalized EBITDA
-349.82
-143.15%
810.77
+910.34%
80.25
-98.05%
4,112.73
Reconciled Depreciation
156.34
-1.08%
158.06
-0.40%
158.70
+2.54%
154.76
EBIT
-534.16
+30.47%
-768.22
+3.60%
-796.92
-7.33%
-742.46
Total Unusual Items
-28.00
+98.03%
-1,420.94
-97.77%
-718.47
+84.71%
-4,700.43
Total Unusual Items Excluding Goodwill
-28.00
+98.03%
-1,420.94
-97.77%
-718.47
+84.71%
-4,700.43
Special Income Charges
-28.00
+98.03%
-1,420.94
-97.77%
-718.47
+84.71%
-4,700.43
Impairment Of Capital Assets
28.00
-98.03%
1,420.94
+97.77%
718.47
-84.71%
4,700.43
Net Income
-408.35
+79.85%
-2,027.01
-38.30%
-1,465.68
+72.85%
-5,399.10
Pretax Income
-534.50
+75.28%
-2,162.36
-43.43%
-1,507.64
+72.29%
-5,441.39
Net Non Operating Interest Income Expense
28.65
+7.18%
26.73
+236.10%
7.95
+357.13%
1.74
Net Interest Income
28.65
+7.18%
26.73
+236.10%
7.95
+357.13%
1.74
Interest Income Non Operating
28.65
+7.18%
26.73
+236.10%
7.95
+357.13%
1.74
Interest Income
28.65
+7.18%
26.73
+236.10%
7.95
+357.13%
1.74
Other Income Expense
-28.99
+97.96%
-1,420.87
-97.71%
-718.67
+84.71%
-4,700.67
Other Non Operating Income Expenses
-0.99
-1651.56%
0.06
+130.77%
-0.21
+12.61%
-0.24
Tax Provision
-126.15
+6.80%
-135.36
-222.65%
-41.95
+0.80%
-42.29
Tax Rate For Calcs
0.00
+277.05%
0.00
+124.96%
0.00
+258.03%
0.00
Tax Effect Of Unusual Items
-6.61
+92.57%
-88.95
-344.91%
-19.99
+45.27%
-36.53
Net Income Including Noncontrolling Interests
-408.35
+79.85%
-2,027.01
-38.30%
-1,465.68
+72.85%
-5,399.10
Net Income From Continuing Operation Net Minority Interest
-408.35
+79.85%
-2,027.01
-38.30%
-1,465.68
+72.85%
-5,399.10
Net Income From Continuing And Discontinued Operation
-408.35
+79.85%
-2,027.01
-38.30%
-1,465.68
+72.85%
-5,399.10
Net Income Continuous Operations
-408.35
+79.85%
-2,027.01
-38.30%
-1,465.68
+72.85%
-5,399.10
Normalized Income
-386.96
+44.32%
-695.01
+9.41%
-767.21
-4.35%
-735.20
Net Income Common Stockholders
-408.35
+79.85%
-2,027.01
-38.30%
-1,465.68
+72.85%
-5,399.10
Diluted EPS
-11.11
+82.51%
-63.54
-34.60%
-47.21
+72.85%
-173.89
Basic EPS
-11.11
+82.51%
-63.54
-34.60%
-47.21
+72.85%
-173.89
Basic Average Shares
36.75
+15.21%
31.90
+2.74%
31.05
+0.00%
31.05
Diluted Average Shares
36.75
+15.21%
31.90
+2.74%
31.05
+0.00%
31.05
Diluted NI Availto Com Stockholders
-408.35
+79.85%
-2,027.01
-38.30%
-1,465.68
+72.85%
-5,399.10
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
2,922.01
-2.05%
2,983.31
-23.77%
3,913.81
-20.74%
4,937.99
Current Assets
953.85
+16.34%
819.86
+425.33%
156.06
-47.21%
295.63
Cash Cash Equivalents And Short Term Investments
904.43
+18.46%
763.47
+684.76%
97.29
-59.73%
241.60
Cash And Cash Equivalents
249.73
+16.57%
214.23
+120.21%
97.29
-59.73%
241.60
Other Short Term Investments
654.70
+19.20%
549.24
0.00
—
Receivables
18.30
-9.93%
20.31
-14.43%
23.74
+20.09%
19.77
Accounts Receivable
18.30
-9.93%
20.31
+19.89%
16.94
+10.40%
15.35
Gross Accounts Receivable
21.90
-9.18%
24.11
+20.31%
20.04
+30.60%
15.35
Allowance For Doubtful Accounts Receivable
-3.60
+5.16%
-3.80
-22.58%
-3.10
—
Taxes Receivable
—
4.47
-34.15%
6.79
+64.19%
4.14
Inventory
16.02
-14.03%
18.63
-14.12%
21.70
+9.82%
19.75
Raw Materials
16.02
-14.03%
18.63
-14.12%
21.70
+9.82%
19.75
Prepaid Assets
—
12.97
-2.80%
13.35
-8.06%
14.52
Other Current Assets
15.11
-13.41%
17.45
-13.20%
20.10
+7.75%
18.66
Total Non Current Assets
1,968.17
-9.03%
2,163.45
-42.43%
3,757.75
-19.06%
4,642.35
Net PPE
103.88
-23.30%
135.43
-20.04%
169.38
-14.77%
198.72
Gross PPE
174.34
-7.91%
189.31
-7.62%
204.93
-5.88%
217.73
Accumulated Depreciation
-70.45
-30.76%
-53.88
-51.58%
-35.55
-87.05%
-19.00
Properties
0.00
0.00
0.00
0.00
Machinery Furniture Equipment
7.58
-9.01%
8.33
+9.40%
7.62
-25.48%
10.22
Construction In Progress
0.80
-37.96%
1.30
-83.73%
7.97
-25.19%
10.65
Other Properties
106.18
-11.46%
119.92
-8.39%
130.91
-7.45%
141.45
Leases
59.77
+0.01%
59.76
+2.27%
58.44
+5.46%
55.41
Goodwill And Other Intangible Assets
1,850.56
-8.25%
2,016.89
-43.60%
3,576.16
-19.33%
4,432.96
Goodwill
—
0.00
-100.00%
888.94
-40.63%
1,497.40
Other Intangible Assets
1,850.56
-8.25%
2,016.89
-24.95%
2,687.22
-8.46%
2,935.56
Other Non Current Assets
13.73
+23.42%
11.12
-8.90%
12.21
+14.40%
10.67
Total Liabilities Net Minority Interest
344.15
-28.29%
479.90
+79.32%
267.63
-8.29%
291.82
Current Liabilities
79.67
+3.57%
76.92
-52.98%
163.61
+21.25%
134.94
Payables And Accrued Expenses
29.73
+7.89%
27.55
-47.00%
51.99
+17.13%
44.39
Payables
2.08
-57.00%
4.84
-75.38%
19.67
+12.54%
17.48
Accounts Payable
2.08
-57.00%
4.84
-75.38%
19.67
+29.52%
15.19
Current Accrued Expenses
27.65
+21.73%
22.71
-29.74%
32.32
+20.12%
26.91
Pensionand Other Post Retirement Benefit Plans Current
36.30
+5.12%
34.53
-64.03%
96.00
+29.54%
74.10
Current Debt And Capital Lease Obligation
11.71
-11.65%
13.26
-10.46%
14.81
+11.05%
13.34
Current Capital Lease Obligation
11.71
-11.65%
13.26
-10.46%
14.81
+11.05%
13.34
Other Current Liabilities
1.93
+21.96%
1.58
+95.30%
0.81
-74.00%
3.11
Total Non Current Liabilities Net Minority Interest
264.48
-34.37%
402.98
+287.41%
104.02
-33.70%
156.88
Long Term Debt And Capital Lease Obligation
43.15
-21.38%
54.88
-21.15%
69.60
-15.82%
82.67
Long Term Capital Lease Obligation
43.15
-21.38%
54.88
-21.15%
69.60
-15.82%
82.67
Non Current Deferred Liabilities
218.58
-36.80%
345.86
+950.58%
32.92
-53.68%
71.08
Non Current Deferred Taxes Liabilities
218.58
-36.80%
345.86
+950.58%
32.92
-53.68%
71.08
Other Non Current Liabilities
2.75
+23.08%
2.24
+49.27%
1.50
-52.20%
3.13
Stockholders Equity
2,577.86
+2.97%
2,503.41
0.00
0.00
Common Stock Equity
2,577.86
+2.97%
2,503.41
-31.34%
3,646.19
-21.52%
4,646.16
Capital Stock
0.04
+17.65%
0.03
—
—
Common Stock
0.04
+17.65%
0.03
—
—
Preferred Stock
0.00
0.00
—
—
Share Issued
40.33
+18.99%
33.89
+8.98%
31.10
+0.00%
31.10
Ordinary Shares Number
40.33
+18.99%
33.89
+8.98%
31.10
+0.00%
31.10
Additional Paid In Capital
12,786.85
+3.91%
12,305.25
—
—
Retained Earnings
-10,211.68
-4.17%
-9,803.33
-26.07%
-7,776.32
-23.23%
-6,310.64
Gains Losses Not Affecting Retained Earnings
2.65
+82.98%
1.45
+36.12%
1.07
+19.24%
0.89
Other Equity Adjustments
2.65
+82.98%
1.45
—
—
Total Equity Gross Minority Interest
2,577.86
+2.97%
2,503.41
-31.34%
3,646.19
-21.52%
4,646.16
Total Capitalization
2,577.86
+2.97%
2,503.41
-31.34%
3,646.19
-21.52%
4,646.16
Working Capital
874.18
+17.67%
742.94
+9946.73%
-7.54
-104.70%
160.69
Invested Capital
2,577.86
+2.97%
2,503.41
-31.34%
3,646.19
-21.52%
4,646.16
Total Debt
54.86
-19.49%
68.14
-19.27%
84.41
-12.09%
96.01
Capital Lease Obligations
54.86
-19.49%
68.14
-19.27%
84.41
-12.09%
96.01
Net Tangible Assets
727.31
+49.49%
486.51
+113.60%
-3,576.16
+19.33%
-4,432.96
Tangible Book Value
727.31
+49.49%
486.51
+594.74%
70.03
-67.15%
213.20
Duefrom Related Parties Current
—
—
0.12
-56.94%
0.28
Dueto Related Parties Current
—
—
0.83
-63.87%
2.29
Limited Partnership Capital
—
—
11,421.45
+4.25%
10,955.91
Total Partnership Capital
—
—
3,646.19
-21.52%
4,646.16
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-299.01
+48.19%
-577.16
+3.13%
-595.80
-6.14%
-561.31
Cash Flow From Continuing Operating Activities
-299.01
+48.19%
-577.16
+3.13%
-595.80
-6.14%
-561.31
Net Income From Continuing Operations
-408.35
+79.85%
-2,027.01
-38.30%
-1,465.68
+72.85%
-5,399.10
Depreciation Amortization Depletion
156.34
-1.08%
158.06
-0.40%
158.70
+2.54%
154.76
Depreciation
18.01
-8.69%
19.72
-3.15%
20.36
+23.94%
16.43
Amortization Cash Flow
138.33
+0.00%
138.33
+0.00%
138.33
+0.00%
138.33
Depreciation And Amortization
156.34
-1.08%
158.06
-0.40%
158.70
+2.54%
154.76
Amortization Of Intangibles
138.33
+0.00%
138.33
+0.00%
138.33
+0.00%
138.33
Other Non Cash Items
1.35
+102.52%
-53.53
+27.74%
-74.08
-87.02%
-39.61
Stock Based Compensation
58.28
-32.30%
86.08
-11.47%
97.23
+28.40%
75.73
Asset Impairment Charge
28.33
-98.01%
1,420.94
+97.77%
718.47
-84.71%
4,700.43
Deferred Tax
-126.15
+6.03%
-134.25
-251.88%
-38.15
+2.33%
-39.06
Deferred Income Tax
-126.15
+6.03%
-134.25
-251.88%
-38.15
+2.33%
-39.06
Change In Working Capital
12.41
+151.11%
-24.28
-414.44%
7.72
+153.38%
-14.46
Change In Receivables
1.69
+150.00%
-3.37
-143.67%
-1.38
+84.06%
-8.68
Changes In Account Receivables
1.69
+150.00%
-3.37
-143.67%
-1.38
+84.06%
-8.68
Change In Inventory
2.62
-14.90%
3.07
+258.40%
-1.94
+86.22%
-14.08
Change In Prepaid Assets
3.36
+84.31%
1.82
+300.77%
-0.91
+91.37%
-10.53
Change In Payables And Accrued Expense
3.72
+113.51%
-27.55
-625.78%
5.24
-62.29%
13.90
Change In Accrued Expense
6.46
+149.98%
-12.92
-649.38%
2.35
-79.66%
11.56
Change In Payable
-2.73
+81.33%
-14.63
-606.58%
2.89
+23.46%
2.34
Change In Account Payable
-2.73
+81.33%
-14.63
-606.58%
2.89
+23.46%
2.34
Change In Other Working Capital
1.02
-41.33%
1.75
-73.97%
6.71
+36.31%
4.92
Investing Cash Flow
-85.05
+84.56%
-551.01
-4175.71%
-12.89
+43.62%
-22.86
Cash Flow From Continuing Investing Activities
-85.05
+84.56%
-551.01
-4175.71%
-12.89
+43.62%
-22.86
Net PPE Purchase And Sale
-0.91
+82.55%
-5.21
+59.59%
-12.89
+43.62%
-22.86
Purchase Of PPE
-0.91
+82.55%
-5.21
+59.59%
-12.89
+43.62%
-22.86
Capital Expenditure
-0.91
+82.55%
-5.21
+59.59%
-12.89
+43.62%
-22.86
Net Investment Purchase And Sale
-84.14
+84.58%
-545.80
0.00
0.00
Purchase Of Investment
-1,308.34
-139.71%
-545.80
0.00
0.00
Sale Of Investment
1,224.20
0.00
0.00
0.00
Financing Cash Flow
423.32
-65.98%
1,244.30
+168.30%
463.77
-23.32%
604.82
Cash Flow From Continuing Financing Activities
423.32
-65.98%
1,244.30
+168.30%
463.77
-23.32%
604.82
Net Common Stock Issuance
418.80
0.00
0.00
—
Proceeds From Stock Option Exercised
4.53
0.00
0.00
0.00
Net Other Financing Charges
—
1,244.30
+168.30%
463.77
-23.32%
604.82
Changes In Cash
39.27
-66.19%
116.13
+180.14%
-144.92
-801.97%
20.64
Effect Of Exchange Rate Changes
-0.15
-137.10%
-0.06
-120.33%
0.30
+159.69%
-0.51
Beginning Cash Position
217.58
+114.34%
101.51
-58.76%
246.13
+8.91%
225.99
End Cash Position
256.70
+17.98%
217.58
+114.34%
101.51
-58.76%
246.13
Free Cash Flow
-299.92
+48.50%
-582.36
+4.32%
-608.69
-4.20%
-584.17
Amortization Of Securities
-21.22
-569.94%
-3.17
0.00
0.00
Common Stock Issuance
418.80
0.00
0.00
—
Issuance Of Capital Stock
418.80
0.00
0.00
—
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category